Skip to main content
. 2015 Jun 9;6(2):143–152. doi: 10.1007/s13300-015-0115-1

Table 4.

Occurrence of hypoglycemic events during the on-treatment period

Hypoglycemia definition Hypoglycemia at any time of day (24 h) Nocturnal hypoglycemia (00:00–05:59 h)
Gla-300a
(N = 20)
Gla-100a
(N = 20)
Gla-300a
(N = 20)
Gla-100a
(N = 20)
Any hypoglycemia
 Participants experiencing ≥1 event during the treatment period, n (%) 17 (85.0) 20 (100.0) 4 (20.0) 8 (40.0)
 Total number of events during the treatment period 126 192 6 20
Confirmed (≤3.9 mmol L−1 [≤70 mg dL−1]) or severe hypoglycemiab
 Participants experiencing ≥1 event during the treatment period, n (%) 17 (85.0) 20 (100.0) 4 (20.0) 8 (40.0)
 Total number of events during the treatment period 126 189 6 20
Confirmed (<3.0 mmol L−1 [<54 mg dL−1]) or severe hypoglycemiab
 Participants experiencing ≥1 event during the treatment period, n (%) 8 (40.0) 12 (60.0) 1 (5.0) 4 (20.0)
 Total number of events during the treatment period 28 44 1 6

Gla-300 insulin glargine 300 U mL−1, Gla-100 insulin glargine 100 U mL−1

aData pooled from subgroups 1 and 2 by treatment

bConfirmed or severe hypoglycemia includes documented symptomatic, asymptomatic and severe hypoglycemia